CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 89 filers reported holding CULLINAN ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,720,442 | +84008.7% | 1,074,082 | 0.0% | 0.52% | -3.5% |
| Q2 2023 | $11,557 | +5.2% | 1,074,082 | 0.0% | 0.54% | -0.7% |
| Q1 2023 | $10,988 | -99.9% | 1,074,082 | 0.0% | 0.54% | -9.5% |
| Q4 2022 | $11,331,565 | -17.7% | 1,074,082 | 0.0% | 0.60% | -22.9% |
| Q3 2022 | $13,770,000 | 0.0% | 1,074,082 | 0.0% | 0.77% | -11.2% |
| Q2 2022 | $13,770,000 | +22.4% | 1,074,082 | 0.0% | 0.87% | +50.9% |
| Q1 2022 | $11,246,000 | -32.1% | 1,074,082 | 0.0% | 0.58% | -10.2% |
| Q4 2021 | $16,573,000 | -31.6% | 1,074,082 | 0.0% | 0.64% | -24.0% |
| Q3 2021 | $24,242,000 | -12.4% | 1,074,082 | 0.0% | 0.85% | -13.2% |
| Q2 2021 | $27,658,000 | -38.2% | 1,074,082 | 0.0% | 0.98% | -35.7% |
| Q1 2021 | $44,757,000 | – | 1,074,082 | – | 1.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
| CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
| Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
| BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
| Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
| Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
| SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
| Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |